Phase II trial of low-dose N-(phosphonacetyl)-disodium L-aspartic acid and high-dose 24-hour infusional 5-Fluorouracil in advanced gastric adenocarcinoma: A Southwest Oncology Group study

Roy L. Martino, Thomas R. Fleming, Louise M. Morrell, Bach Ardalan, Stephen P. Richman, John S. Macdonald

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of low-dose N-(phosphonacetyl)-disodium L-aspartic acid and high-dose 24-hour infusional 5-Fluorouracil in advanced gastric adenocarcinoma: A Southwest Oncology Group study'. Together they form a unique fingerprint.

Medicine & Life Sciences